BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 20, 2001
View Archived Issues
European MAA submitted for Onzar in the treatment of cutaneous T-cell lymphoma
Read More
BMS submits NDA for Vanlev for the treatment of hypertension
Read More
Cangene seeks approval for antihepatitis B hyperimmune in Canada
Read More
FDA completes IND review of candidate anti-HIV drug TMC-125
Read More
Boehringer Ingelheim submits U.S. NDA for Spiriva in chronic obstructive pulmonary disease
Read More
Progen receives funding for malaria vaccine projects
Read More
Initiation of phase II trial of Ceplene in triple-drug combination therapy
Read More
Activax vaccine component enters clinical testing for prevention of travelers' diseases
Read More
Patient enrollment completed for phase III trial of Neovastat in renal cell carcinoma
Read More
Novartis Ophthalmics and Kissei enter license option agreement for novel glaucoma agent
Read More
Encouraging oral insulin results obtained with BioSante's CAP delivery system
Read More
Boehringer Ingelheim and Structural Bioinformatics jointly research HIV protein targets
Read More
TMC-114: preclinical and early clinical results discussed at ICAAC
Read More
Broad-spectrum antiherpesvirus agents presented by Pharmacia in Chicago
Read More
DNA-interacting compounds under development at GeneSoft as antibacterial agents
Read More
ICAAC news: more on efflux pump inhibitors in development at Essential Therapeutics and Daiichi
Read More
Data presented at this year's ICAAC meeting support continued development of anidulafungin
Read More
Bay-41-4109 characterized at ICAAC as a novel, promising anti-HBV agent
Read More
Update on clinical status of E-7070
Read More
Clinical-stage heart failure therapeutic available for licensing from Banyu
Read More
Urokinase inhibitors identified by Abbott as antiangiogenic agents
Read More
Abbott researchers present benzonitrile-based protein farnesyltransferase inhibitors
Read More
Potential new therapeutic agents for BPH in development at Merck
Read More
Indian researchers discover antimalarial compounds
Read More
NMDA receptor antagonists and their use disclosed by Roche
Read More
Promoters of fibrinolysis designed at Torii as new antithrombotic drugs
Read More
Japanese companies decide not to seek approval in Japan for clinprost
Read More